South Africa has the world's highest absolute burden of tuberculosis, with approximately 300,000 new cases and 55,000 deaths annually, disproportionately affecting HIV-positive individuals and mineworkers. The TB Elimination Acceleration Programme targets a 90% reduction in TB incidence and mortality by 2030, aligned with the End TB Strategy. Key interventions include universal drug susceptibility testing, expanded access to bedaquiline-based regimens for drug-resistant TB, community-based active case finding, and workplace TB screening in mining. The Department of Health's TB Directorate coordinates with the National Health Laboratory Service (NHLS) and NGO partners. TB imposes a direct labour productivity cost — an estimated 0.5% of GDP annually in lost working days and treatment costs. As of early 2026, TB incidence is declining but remains far above elimination thresholds; funding gaps at provincial health departments constrain programme scale-up.
Growth
Feasibility
First raised: May 2021Last discussed: Jun 2025
Health Systemspartially implementedMedium TermDormant
South Africa's primary healthcare (PHC) platform—comprising 3,500 public health facilities plus approximately 72,000 community health workers (CHWs) deployed through the Ward-Based PHC Outreach Teams (WBPHCOT) model—is the structural foundation for NHI. This reform consolidates the CHW programme as a formal, paid tier of the health system, implements the integrated patient registration system (IPRS) across all PHC facilities, and deploys the digital health record system (HPRS) to enable continuity of care. The PEPFAR funding transition (id=105) makes CHW formalisation urgent: an estimated 15,000 CHWs employed through PEPFAR-funded NGOs face retrenchment as US funding winds down, creating a cliff in community-level HIV/TB service delivery. The PC on Health BRRRs 2022–2024 repeatedly flagged CHW contractualisation and the absence of a national employment framework as the central gap. Cost estimates: R8–12 billion annually for full CHW formalisation, partially offset by reduced hospital admissions.
The Competition Commission's Health Market Inquiry (HMI), which reported in September 2019 after five years of investigation, found that South Africa's private healthcare market is characterised by systemically high prices driven by concentrated hospital group power, inadequate price transparency, and a medical scheme system that fails to effectively represent patient interests against providers. The HMI's 140+ recommendations include: mandatory multi-funder contracting (hospital groups cannot negotiate individually with each medical scheme), a National Reference Price List (NRPL) setting benchmark tariffs for all procedures, compulsory quality reporting by all private hospitals and specialists, and a new market conduct regulator for the healthcare sector. Implementation has been slow: the NRPL has been delayed by legal challenges from private hospital groups and specialist associations (HASA, SAMA), and the Council for Medical Schemes (CMS) lacks enforcement capacity. The MTBPS 2025 notes that private healthcare costs constitute 45% of total health spending despite serving only 16% of the population—a resource allocation that NHI implementation must address structurally. The PC on Health BRRRs 2021–2024 consistently flag HMI implementation delays as a governance failure.
South Africa's mental health system is severely under-resourced: fewer than 20 psychiatrists per million people (WHO recommends 1 per 10,000), 95% of mental health funding allocated to acute psychiatric hospitals rather than community-based care, and an estimated 75% of people with diagnosable mental health conditions receiving no treatment. The Life Esidimeni tragedy (2017), in which 144 mentally ill patients died after the Gauteng DOH terminated psychiatric care contracts and transferred patients to unregistered NGOs, exposed the catastrophic consequences of mental health service failures. The Mental Health Care Act Amendment (under preparation since 2020) proposes: community care mandates for provincial health departments, a minimum psychiatric bed ratio per district, recognition of community-based mental health workers as a formal health cadre, and a dedicated Mental Health Conditional Grant (currently mental health is unfunded within the PHC grant). The 2025 MTBPS does not include a dedicated mental health appropriation, making the structural reform dependent on the NHI implementation framework. The PC on Health BRRRs identify Life Esidimeni docket follow-up and provincial psychiatric bed capacity as the two most repeated mental health recommendations.
The National Health Insurance Act (signed June 2023) establishes the legal framework for a single-payer health financing system that will pool public and private healthcare funding, contract accredited health service providers, and guarantee universal access to a defined package of services. The NHI Fund is to be operationalised in phases: Phase 1 (2023–2026) focuses on registering health users and providers, establishing governance structures, and piloting primary care contracting in selected districts. Full implementation, including mandatory enrolment and the transfer of private medical scheme members, is envisioned post-2030. Costing remains deeply contested: National Treasury estimates put the full NHI at R200–300 billion annually (current combined public and private health spending is R650 billion), but critics argue the model requires R450+ billion given expanded benefits and population. The World Bank, IMF, and rating agencies have flagged NHI fiscal risk as a sovereign concern. The PC on Health BRRRs 2023–2024 note that Phase 1 implementation is behind schedule on provider accreditation and ICT system procurement. This idea's reform requirement is essentially: develop a credible, costed, phased implementation plan that can survive actuarial scrutiny before Phase 2 commitments are locked in.
South Africa's tobacco control framework has not been substantively updated since the Tobacco Products Control Act (1993), despite the global proliferation of electronic nicotine delivery systems (ENDS), heated tobacco products, and waterpipes. The Tobacco Products and Electronic Delivery Systems Control Bill — providing for plain packaging, comprehensive advertising bans, and regulation of ENDS products — was tabled in 2018 and approved by Cabinet in 2022 but has been delayed by industry lobbying, jurisdictional disputes between the Departments of Health and Trade, Industry and Competition, and concerns about tax revenue implications. South Africa is a signatory to the WHO Framework Convention on Tobacco Control (FCTC), creating an international obligation to enact these measures. The PC on Health's BRRRs consistently flagged the Bill's stalled progress as a public health governance failure.